These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33819623)

  • 1. Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles.
    Eskandari Z; Bahadori F; Yapaoz MA; Yenigun VB; Celikten M; Kocyigit A; Onyuksel H
    Eur J Pharm Sci; 2021 Jul; 162():105830. PubMed ID: 33819623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.
    Onyüksel H; Mohanty PS; Rubinstein I
    Int J Pharm; 2009 Jan; 365(1-2):157-61. PubMed ID: 18793708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
    Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
    Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
    Jayawardena D; Anbazhagan AN; Guzman G; Dudeja PK; Onyuksel H
    Mol Pharm; 2017 Nov; 14(11):3698-3708. PubMed ID: 28991483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells.
    Rubinstein I; Soos I; Onyuksel H
    Chem Biol Interact; 2008 Jan; 171(2):190-4. PubMed ID: 17499651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles.
    Lim SB; Rubinstein I; Onyüksel H
    Int J Pharm; 2008 May; 356(1-2):345-50. PubMed ID: 18289811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
    Gao W; Ye G; Duan X; Yang X; Yang VC
    Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.
    Onyüksel H; Ikezaki H; Patel M; Gao XP; Rubinstein I
    Pharm Res; 1999 Jan; 16(1):155-60. PubMed ID: 9950295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.
    Sethi V; Rubinstein I; Kuzmis A; Kastrissios H; Artwohl J; Onyuksel H
    Mol Pharm; 2013 Feb; 10(2):728-38. PubMed ID: 23211088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.
    Dagar S; Sekosan M; Lee BS; Rubinstein I; Onyüksel H
    J Control Release; 2001 Jul; 74(1-3):129-34. PubMed ID: 11489489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule.
    Dulari Jayawardena ; Arivarasu N Anbazhagan ; Priyamvada S; Kumar A; Saksena S; Onyuksel H; Pradeep K Dudeja
    Nanomedicine (Lond); 2020 Oct; 15(25):2459-2474. PubMed ID: 32975467
    [No Abstract]   [Full Text] [Related]  

  • 12. Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells.
    Gülçür E; Thaqi M; Khaja F; Kuzmis A; Önyüksel H
    Drug Deliv Transl Res; 2013 Dec; 3(6):. PubMed ID: 24363979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
    Krishnadas A; Rubinstein I; Onyüksel H
    Pharm Res; 2003 Feb; 20(2):297-302. PubMed ID: 12636171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid Micelles for Peptide Drug Delivery.
    Esparza K; Jayawardena D; Onyuksel H
    Methods Mol Biol; 2019; 2000():43-57. PubMed ID: 31148007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Co-delivery of Pirarubicin and Vinorelbine by Micelles for the Treatment of Breast Cancer].
    Chen D; Zhou HL; Zhao T; Guo CQ; Zhang RP; Li J; Gong T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):612-618. PubMed ID: 34323039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.
    Koo OM; Rubinstein I; Onyüksel H
    Pharm Res; 2011 Apr; 28(4):776-87. PubMed ID: 21132352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM; Rubinstein I; Onyuksel H
    Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP-targeted Cytotoxic Nanomedicine for Breast Cancer.
    Dagar A; Kuzmis A; Rubinstein I; Sekosan M; Onyuksel H
    Drug Deliv Transl Res; 2012 Dec; 2(6):454-62. PubMed ID: 23336096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peptide nanomedicine for treatment of pancreatogenic diabetes.
    Banerjee A; Onyuksel H
    Nanomedicine; 2013 Aug; 9(6):722-8. PubMed ID: 23347897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo.
    Zhu Y; Wang X; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2017 Mar; 250():9-19. PubMed ID: 28163212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.